Atlas Therapeutics Corporation Logo
MYO-T12(R) is Now Available on Bodybuilding.com
December 06, 2011 15:54 ET | Atlas Therapeutics Corporation
MARINA DEL REY, Calif., Dec. 6, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH), dba The Muscle Company, is proud to announce that its innovative product, MYO-T12® is now...
Atlas Therapeutics Corporation Logo
Atlas Therapeutics Releases Corporate Video and Provides Investor Updates
November 29, 2011 19:20 ET | Atlas Therapeutics Corporation
MARINA DEL REY, Calif., Nov. 29, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH) (the "Company"), the distributor and marketer of the world's only clinically validated myostatin...
Atlas Therapeutics Corporation Logo
Atlas Therapeutics Corporation and MYO-T12 Sponsor World Renowned Jiu-Jitsu and MMA Champion Daniel Gracie
October 14, 2011 07:00 ET | Atlas Therapeutics Corporation
MARINA DEL REY, Calif., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH), the manufacturer of the innovative myostatin inhibitor, MYO-T12(R), has announced that it will be...
Atlas Therapeutics Corporation Logo
MYO-T12(R) is Now Available on Amazon.com
July 26, 2011 11:54 ET | Atlas Therapeutics Corporation
MARINA DEL REY, Calif., July 26, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH), dba The Muscle Company, is proud to announce that its innovative product, MYO-T12®, is now...
MYO-T12 ad
Photo Release -- Atlas Therapeutics Launches Online Media Blitz for MYO-T12(R)
July 22, 2011 11:48 ET | Atlas Therapeutics Corporation
MARINA DEL REY, Calif., July 22, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH), parent company of The Muscle Company, launches online media blitz to support the re-launch of...
Atlas Therapeutics Corporation Logo
Obesity Research and Treatment Expert, Dr. Louis Aronne, Joins Atlas Therapeutics' Board of Directors
July 21, 2011 19:43 ET | Atlas Therapeutics Corporation
MARINA DEL REY, Calif., July 21, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH), the manufacturer of the innovative myostatin inhibitor, MYO-T12(R), has announced that Dr. Louis...